{"changes":[],"country":"GB","description":"Alchemab develops antibody therapeutics by studying immune responses in disease-resistant individuals. It serves patients with hard-to-treat diseases through nature-inspired antibody discovery. Differentiator: adaptive immunity datasets fused with deep learning identify protective antibodies from resilient populations.","domain":"alchemab.com","employees":null,"founded":2019,"fundingTotalQuarantined":false,"githubOrg":null,"githubStars":null,"industry":"bio","investors":[],"lat":51.507446,"lng":-0.127765,"location":"London","name":"Alchemab Therapeutics","rounds":[{"amountQuarantined":false,"amountUsd":27000000,"currency":"USD","date":"2025-09-01","investors":[],"leadInvestor":null,"source":{"fact":"round","publisher":"sifted","retrievedAt":"2026-05-16","status":"attributed","url":null},"status":"attributed","type":"series-a","url":null}],"slug":"alchemab-com","sources":[{"fact":"round","publisher":"sifted","retrievedAt":"2026-05-16","status":"attributed","url":null},{"fact":"existence","publisher":"alchemab.com","retrievedAt":"2026-05-16","status":"self-reported","url":"https://alchemab.com"},{"fact":"description","publisher":"alchemab.com","retrievedAt":"2026-05-16","status":"self-reported","url":"https://alchemab.com"}],"stage":"series-a","techStack":["Nginx","Google Analytics","Google Tag Manager","jQuery Migrate 3.4.1","DoubleClick Floodlight","WordPress","WordPress Block Editor","WP Engine","PHP","MySQL","jquery 3."],"totalRaisedUsd":116600000,"updatedAt":"2026-05-16"}